- The Swedish pharmaceutical market continued to grow at
6.7%.
- Tamro Sweden's net sales came to EUR 1,487.0 million (1,573.8).
In local currency net sales grew by 3.5%.
- Internally Tamro Sweden will concentrate on efficiency
of operations and the overall quality of services.
Operating environment and markets
The Swedish pharmaceutical market continued to grow at 6.7%
in 2001. Parallel importers' share of the aggregate sales
grew by over 12% and was 9.3% of the whole market. Pharmaceutical
sales in terms of pharmacy purchasing prices rose to EUR 2,335
million.
In June, the Swedish Competition Authority issued a decision
stating that the plans elaborated by Apoteket AB to develop
its operations do not violate competition laws. After Apoteket
AB published its plan in autumn 2000, several complaints were
filed with the Swedish Competition Authority. Apoteket then
revised its original plans so that its branching out will
not compete with the distribution operations of Tamro and
other pharmaceutical companies. The Swedish Competition Authority
stressed that pharmaceutical wholesalers will continue to
be responsible for distribution to all pharmacies.
During autumn 2001 the Swedish government proposed that pharmacies
switch from expensive products to the cheapest similar products.
Thus generic substitution will be mandatory unless the prescriber
actively forbids it.
Financial performance and operations
Tamro Sweden's net sales came to EUR 1,487.0 million (1,573.8).
In local currency net sales grew by 3.5%. Pharmaceutical sales
accounted for 80% of the total sales. Tamro Sweden's operating
profit improved, which can be explained by higher sales, compensation
related to year 2000 and better cost control in operating
costs. IT costs have decreased substantially compared to the
previous year. Tamro Sweden employed an average of 519 (578)
people in 2001.
Internet-based information services both to suppliers and
pharmacies were developed during the year. Tamro Web Analysis
is designed for suppliers and it offers an information system
for stocks and sales. The suppliers have access to sales statistics,
transactions, back order information and certain key performance
indicators. All information is updated on a daily basis.
Tamro Web Direct, another Internet-based application, has
been developed to complement Tamro Sweden's customer service
provided to pharmacies. Each pharmacy can easily and quickly
find valuable real time operational information about orders,
deliveries, back orders and stocks.
Outlook for 2002
The pharmaceutical market will continue to grow, but, according
to authorities' estimates, at a slower pace, the focus being
on healthcare cost containment. Internally Tamro Sweden will
concentrate on efficiency of operations and the overall quality
of services in order to guarantee added value for customers'
operations. The development of the Tamro's highly competitive
business information systems will continue at a rapid pace
to provide customers with real time business information.
|